Investor Relations

SEC Filings

Document Details

Form
Filing Date
Feb 16, 2021
Document Date
Dec 31, 2020
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.